Clinical Focus

    Next Articles

Advances in the treatment of idiopathic membranous nephropathy

  

  1. 1.Department of Nephrology,  the Second Hospital of Hebei Medical University,  Institute of Nephrology, 
    Hebei Medical University, Shijiazhuang 050000,  China; 2. Department of Nephrology,  the Hospital
    of Traditional Chinese Medical of Shexian,  Shexian 056400,  China
  • Online:2019-12-20 Published:2020-01-19
  • Contact: Corresponding author: Fu Shuxia, Email: fushuxia99@163.com

Abstract: The immunosuppressive therapy for idiopathic membranous nephropathy(IMN) with nephrotic syndrome is mainly a routine therapeutic modality to relieve proteinuria and stabilize renal function.This article summarizes the progress of calcineurin inhibitors and rituximab to IMN with nephrotic syndrome.

Key words: glomerulonephritis, , membranous;nephrotic syndrome, immunosuppressive agents;calcineurininhibitors;rituximab